Clinical Trials

NCT07170462 | RECRUITING | EARLY_PHASE1
50 participants

Cranberry and Gut Health in Crohn's Disease

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-20
Start Date:
2025-10-29
Completion:
2026-08-15
Conditions
  • Crohn Disease (CD)
  • Crohn Disease
Interventions
  • DRUG
  • DIETARY_SUPPLEMENT
No Results Yet
NCT07142564 | NOT_YET_RECRUITING | EARLY_PHASE1
100 participants

Carrier Care: An Innovative Approach to Support Small Babies in the NICU

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-20
Start Date:
2026-09-01
Completion:
2027-12-31
Conditions
  • Group 1: Carrier Care (CC) Followed by Skin-to-Skin Care (SSC) Followed by Family Choice
  • Group 2: Skin-to-Skin Care (SSC) Followed by Carrier Care (CC) Followed by Family Choice
Interventions
  • OTHER
No Results Yet
NCT07098364 | RECRUITING | PHASE1/PHASE2
33 participants

ST-067 in Combination With CD19-Directed CAR T-Cell Therapy (Liso-cel) in Relapsed/Refractory Large B-Cell Lymphoma

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-20
Start Date:
2025-12-27
Completion:
2030-10-04
Conditions
  • Recurrent Diffuse Large B-Cell Lymphoma
  • Recurrent Diffuse Large B-Cell Lymphoma, Not Otherwise Specified
  • Recurrent Grade 3b Follicular Lymphoma
  • Recurrent High-Grade B-Cell Lymphoma
  • Recurrent Indolent B-Cell Non-Hodgkin Lymphoma
  • Recurrent Primary Mediastinal Large B-Cell Lymphoma
  • Refractory Diffuse Large B-Cell Lymphoma
  • Refractory Diffuse Large B-Cell Lymphoma, Not Otherwise Specified
  • Refractory Grade 3b Follicular Lymphoma
  • Refractory High-Grade B-Cell Lymphoma
  • Refractory Indolent B-Cell Non-Hodgkin Lymphoma
  • Refractory Primary Mediastinal Large B-Cell Lymphoma
Interventions
  • PROCEDURE
  • BIOLOGICAL
No Results Yet
NCT07089641 | RECRUITING | PHASE1
50 participants

ERAS-801 for the Treatment of Resectable and Progressive or Recurrent or Elderly Newly Diagnosed IDH Wildtype Grade IV Glioblastoma or Gliosarcoma With an EGFR Amplification or Mutation, ERAS801-SARG Trial

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-20
Start Date:
2025-07-28
Completion:
2027-07-30
Conditions
  • Glioblastoma
  • Glioblastoma, IDH-Wildtype
  • Gliosarcoma
  • Recurrent Glioblastoma, IDH-Wildtype
  • Recurrent Gliosarcoma
  • Resectable Glioblastoma
Interventions
  • PROCEDURE
  • DRUG
  • OTHER
No Results Yet
NCT07087912 | RECRUITING | PHASE4
477 participants

Safety and Immunogenicity of the Live Attenuated Tetravalent Butantan-Dengue Vaccine in Autoimmune Rheumatic Diseases

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-20
Start Date:
2026-03-16
Completion:
2027-12-30
Conditions
  • Rheumatoid Arthritis (RA)
  • Juvenile Idiopathic Arthritis (JIA)
  • Systemic Lupus Erythematosus (SLE)
  • Juvenile Systemic Lupus Erythematosus
  • Systemic Sclerosis (SSc)
  • Idiopathic Inflammatory Myopathies (IIMs)
  • Axial Spondyloarthritis
  • Psoriatic Arthritis (PsA)
  • Granulomatosis With Polyangiitis
  • Microscopic Polyangiitis
  • Antiphospholipid Syndrome
  • Takayasu Arteritis
Interventions
  • BIOLOGICAL
No Results Yet
NCT07080242 | RECRUITING | PHASE1
120 participants

Evaluating BL-M14D1 in Subjects With Locally Advanced or Metastatic Small Cell Lung Cancer and Neuroendocrine Tumors

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-20
Start Date:
2025-04-28
Completion:
2027-12-31
Conditions
  • Small Cell Lung Cancer Metastatic or Locally Advanced
  • Neuroendocrine Cancer
  • Metastatic Neuroendocrine Prostate Cancer
  • Metastatic Advanced Poorly Differentiated Gastroenteropancreatic Neuroendocrine Carcinoma
  • Metastatic Advanced Merkel Cell Carcinoma
  • Locally Advanced Large Cell Neuroendocrine Carcinoma of the Lung
  • Locally Advanced Extrapulmonary Neuroendocrine Carcinoma
  • Locally Advanced Neuroendocrine Prostate Cancer
  • Locally Advanced Poorly Differentiated Gastroenteropancreatic Neuroendocrine
  • Locally Advanced Merkel Cell Carcinoma
  • Metastatic Large Cell Neuroendocrine Carcinoma of the Lung
Interventions
  • DRUG
No Results Yet
NCT07046078 | RECRUITING | PHASE2
20 participants

Combination Chemotherapy (FLAG-Ida) Followed Immediately by Reduced-Intensity Total Body Radiation Therapy and Donor Hematopoietic Cell Transplant for the Treatment of Adults Age 60 and Older With Newly Diagnosed Adverse-Risk Acute Myeloid Leukemia or Other High-Grade Myeloid Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-20
Start Date:
2025-09-26
Completion:
2027-06-30
Conditions
  • Acute Leukemia of Ambiguous Lineage
  • Acute Myeloid Leukemia
  • Chronic Myelomonocytic Leukemia
  • Myelodysplastic Syndrome
Interventions
  • PROCEDURE
  • DRUG
  • BIOLOGICAL
  • OTHER
  • RADIATION
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page